FI57256B - Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-laegre-alkyl-2-cyano-2,3-dihydro-1h-1,4-bensodiazepinderivat - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-laegre-alkyl-2-cyano-2,3-dihydro-1h-1,4-bensodiazepinderivat Download PDF

Info

Publication number
FI57256B
FI57256B FI2240/74A FI224074A FI57256B FI 57256 B FI57256 B FI 57256B FI 2240/74 A FI2240/74 A FI 2240/74A FI 224074 A FI224074 A FI 224074A FI 57256 B FI57256 B FI 57256B
Authority
FI
Finland
Prior art keywords
dihydro
cyano
methyl
formula
chloro
Prior art date
Application number
FI2240/74A
Other languages
English (en)
Finnish (fi)
Other versions
FI57256C (fi
FI224074A (sv
Inventor
Robert Ye-Fong Ning
Morton A Schwartz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI224074A publication Critical patent/FI224074A/fi
Publication of FI57256B publication Critical patent/FI57256B/fi
Application granted granted Critical
Publication of FI57256C publication Critical patent/FI57256C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Claims (3)

1. Förfarande för framställning av terapeutiskt användbara 1-lägre-alkyl- 2-cyano-2,3-dihydro-lH-l,U-bensodiazepinderivat med formeln CN X’ 4-¾ väri R sr halogen, R1 är en alkyl med 1~T, fördelaktigt 1-^ kolatcmer, och R^ är väte eller halogen, samt f armaceutiskt användbara syraaddit ions salt er därav, kännetecknat därav, att en 2-hydroxiförening med formeln i1 I /0H N—< R__| y II väri R, R^ och R^ har ovan angivna betydelse, omsättes med cyanväte eller ett reagens som i reaktionsblandningen bildar cyanväte, för att giva motsvarande cyanoförening, och cm sä önskas, överförs den erhällna föreningen i ett farma-ceutiskt användbart syraadditionssalt.
2. Förfarande enligt patentkravet 1 för framställning av 7~klor-2-cyano- 2.3- dihydro-l-metyl-5-fenyl-lH-l,U-bensodiazepin, kännetecknat därav, att s&scm utgängsamne används 7-klor-2,3-dihydro-2-hydroxi-1-metyl-5-feny1-1H-l,U-bensodiazepin.
3. Förfarande enligt patentkravet 1 för framställning av 7-klor-2-cyano- 2.3- dihydro~5~(2-fluorfenyl)-l-metyl-lH-l, i+-bensodiazepin, kännetecknat därav, att säsom utgängsamne används 7-klor-2,3~dihydro-5-(2-fluorfenyl)-2-hydroxi-1-metyl-lH-l,U-bensodiazepin·
FI2240/74A 1973-07-27 1974-07-23 Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-laegre-alkyl-2-cyano-2,3-dihydro-1h-1,4-bensodiazepinderivat FI57256C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US383228A US3925358A (en) 1973-07-27 1973-07-27 1-Lower alkyl-2-substituted-1,4-benzodiazepines
US38322873 1973-07-27

Publications (3)

Publication Number Publication Date
FI224074A FI224074A (sv) 1975-01-28
FI57256B true FI57256B (fi) 1980-03-31
FI57256C FI57256C (fi) 1980-07-10

Family

ID=23512244

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2240/74A FI57256C (fi) 1973-07-27 1974-07-23 Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-laegre-alkyl-2-cyano-2,3-dihydro-1h-1,4-bensodiazepinderivat

Country Status (24)

Country Link
US (1) US3925358A (sv)
JP (1) JPS5041884A (sv)
AR (1) AR210987A1 (sv)
AT (1) AT340430B (sv)
BE (1) BE818132A (sv)
CA (1) CA1024512A (sv)
CH (1) CH602673A5 (sv)
DD (1) DD116038A5 (sv)
DE (1) DE2436147A1 (sv)
DK (1) DK138320B (sv)
ES (1) ES428597A1 (sv)
FI (1) FI57256C (sv)
FR (1) FR2238498B1 (sv)
GB (1) GB1407585A (sv)
HU (1) HU169331B (sv)
IE (1) IE39631B1 (sv)
IL (1) IL45102A (sv)
LU (1) LU70603A1 (sv)
NL (1) NL7410101A (sv)
NO (1) NO137692C (sv)
PH (1) PH11991A (sv)
PL (1) PL89890B1 (sv)
SE (1) SE419445B (sv)
ZA (1) ZA743857B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE13884T1 (de) * 1979-12-24 1985-07-15 Kali Chemie Pharma Gmbh 2-azidomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE2952279A1 (de) 1979-12-24 1981-06-25 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3048264A1 (de) * 1980-12-20 1982-09-09 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3124013A1 (de) * 1981-06-19 1982-12-30 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3481921A (en) * 1965-10-22 1969-12-02 Hoffmann La Roche Benzodiazepines

Also Published As

Publication number Publication date
CA1024512A (en) 1978-01-17
DK138320C (sv) 1979-01-22
FR2238498B1 (sv) 1977-07-08
DE2436147A1 (de) 1975-02-13
LU70603A1 (sv) 1976-06-11
SE7409734L (sv) 1975-01-28
BE818132A (fr) 1975-01-27
AU7169774A (en) 1976-01-29
AT340430B (de) 1977-12-12
GB1407585A (en) 1975-09-24
IE39631L (en) 1975-01-27
SE419445B (sv) 1981-08-03
NO137692C (no) 1978-04-05
ES428597A1 (es) 1976-08-16
IL45102A0 (en) 1974-09-10
DK402774A (sv) 1975-04-01
HU169331B (sv) 1976-11-28
ZA743857B (en) 1975-06-25
ATA617074A (de) 1977-04-15
US3925358A (en) 1975-12-09
DD116038A5 (sv) 1975-11-05
PH11991A (en) 1978-10-05
FI57256C (fi) 1980-07-10
JPS5041884A (sv) 1975-04-16
DK138320B (da) 1978-08-14
PL89890B1 (sv) 1976-12-31
NO137692B (no) 1977-12-27
FI224074A (sv) 1975-01-28
CH602673A5 (sv) 1978-07-31
IL45102A (en) 1978-01-31
NO742738L (sv) 1975-02-24
IE39631B1 (en) 1978-11-22
AR210987A1 (es) 1977-10-14
NL7410101A (nl) 1975-01-29
FR2238498A1 (sv) 1975-02-21

Similar Documents

Publication Publication Date Title
US4097597A (en) Dibenzo b,e! 1,4!diazepines
FI71556B (fi) Foerfarande foer framstaellning av 5-(paradeuterofenyl)-5-fenylhydantoin vilken aer ett laekemedel anvaendbart mot konvulsioner
PL129707B1 (en) Process for preparing novel n-substituted derivatives of aziridine-2-carboxylic acid
KR20100046245A (ko) 정제된 형태의 트라조돈 및 염산 트라조돈
KR20230153533A (ko) 유로리틴 유도체 및 이의 사용 방법
FI57256B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-laegre-alkyl-2-cyano-2,3-dihydro-1h-1,4-bensodiazepinderivat
KR100195421B1 (ko) 6-아미노옥타히드로인돌리진트리올유도체
CA2234342A1 (en) Pancreatitis remedy
KR0164595B1 (ko) 2,3-디하이드로-1-(피리디닐아미노)-인돌, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US4439619A (en) Fluorinated pentene diamine derivatives
SU1731052A3 (ru) Способ получени фенотиазиновых соединений, или их сложных низших алкиловых эфиров, или их фармацевтически приемлемых кислотно-аддитивных солей
RU2768451C1 (ru) Селективный антагонист рецепторов типа A2A
CS207399B2 (en) Method of making the derivates of the benzodiazepine
US3637746A (en) Process for preparing n-aryl-alpha-oxocyclopolymethylene amines an related compounds
US3905956A (en) Tricyclic benzodiazepines
FI65782C (fi) Analogifoerfarande foer framstaellning av terapeutiskt verkande n1-glukofuranosid-6-yl-n3-nitroso-karbamider
US3471471A (en) Adenosine derivatives and therapeutic preparations containing same
Edelman et al. Thymidylate synthetase inhibitors. Synthesis of N-substituted 5-aminomethyl-2'-deoxyuridine 5'-phosphates
Kametani et al. Studies on the synthesis of chemotherapeutics. 12. Synthesis and antitumor activity of N-phthalidyl-5-fluorouracil derivatives
Powers et al. Anticonvulsant properties of selected pyrrolo [2, 3-d] pyrimidine-2, 4-diones and intermediates
US3689657A (en) Indole derivatives in the treatment of skeletal muscle fatigability
SU1258327A3 (ru) Способ получени 7-замещенных 9 @ -метоксимитозана
DE2453212A1 (de) 3-disubstituierte aminoisothiazol eckige klammer auf 3,4-d eckige klammer zu pyrimidine
KR790001068B1 (ko) 벤조디아제핀 유도체의 제조방법
US3880840A (en) Pyrazino-1,4-diazepines